Education
About Us
Working with TipRanks
Follow Us
Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877)
:1877
Comparison Results
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$29.70
HK$42.93B
―
94.12%
1 Buy
1 Hold
1 Sell
Hold
RemeGen Co. Ltd. Class H
HK$106.20
HK$69.69B
―
567.09%
0 Buy
0 Hold
3 Sell
Strong Sell
Shanghai Henlius Biotech, Inc. Class H
HK$75.75
HK$43.04B
46.26
235.18%
1 Buy
0 Hold
0 Sell
Moderate Buy
Ascentage Pharma Group International
HK$73.60
HK$28.69B
―
74.82%
1 Buy
0 Hold
0 Sell
Moderate Buy
Performance Comparison
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
29.70
15.26
105.68%
HK:9688
Zai Lab Ltd
26.18
7.14
37.50%
HK:9966
Alphamab Oncology
13.96
9.99
251.64%
HK:9995
RemeGen Co. Ltd. Class H
106.20
91.28
611.80%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
75.75
53.05
233.70%
HK:6855
Ascentage Pharma Group International
73.60
32.10
77.35%